Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/26730
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bakker, Dennis | - |
dc.contributor.author | Kuijper, Ed J. | - |
dc.date.accessioned | 2022-05-27T12:28:19Z | - |
dc.date.available | 2022-05-27T12:28:19Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.citation | Ergen, E. K. vd. (2009). "Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital". Medecine et Maladies Infectieuses, 39(6), 382-387. | en_US |
dc.identifier.issn | 0399-077X | - |
dc.identifier.uri | https://doi.org/10.1016/j.medmal.2009.02.001 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0399077X09000304 | - |
dc.identifier.uri | http://hdl.handle.net/11452/26730 | - |
dc.description.abstract | Background. - Clostridium difficile (C. difficile) is a well-established cause of nosocomial diarrhea. The aim of our study was to define the incidence of nosocomial diarrhea in our hospital and to determine the role of C. difficile. Additionally, the risk factors for nosocomial diarrhea and Clostridium difficile associated diarrhea (CDAD) were investigated. Methods. - We included all patients, 18 years of age or more, who were admitted to the Uludag Teaching Hospital between October 1, 2004 and February 1, 2005, and developed diarrhea at least three days after hospital admission. A case-control study was per-formed. Results. - The total incidence of nosocomial diarrhea was 0.6 per 1,000 hospitalization-days and 5 per 1,000 patients' admissions. Previous use of chemotherapy was found to be an important predisposing factor for nosocomial diarrhea. The incidence of CDAD was 0.26 per 1,000 hospitalization-days and 2.1 per 1,000 admissions, comparable with incidence rates in Europe. CDAD was diagnosed in 43% of patients with nosocomial diarrhea. No severe cases of CDAD were diagnosed. A correlation was found between CDAD and antibiotic use before admission and during admission in univariate analysis. PCR ribotyping revealed four strains of PCR ribotype 002 and I strain of ribotype 0 12 Out of 5 C difficile strains available for extensive identification. Conclusion. - The incidence rates of nosocomial diarrhea and CDAD are not different than the usual incidence rates in Europe. C. difficile was the causative agent in 43% of patients with nosocomial diarrhea. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier France | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Clostridium difficile | en_US |
dc.subject | Clostridium difficile-associated diarrhea | en_US |
dc.subject | Nosocomial diarrhea | en_US |
dc.subject | Arbitrarily primed pcr | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Toxin production | en_US |
dc.subject | North-america | en_US |
dc.subject | Outbreak | en_US |
dc.subject | Disease | en_US |
dc.subject | Epidemıology | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Gastroenteritis | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Infectious diseases | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Clostridium difficile | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Diarrhea | en_US |
dc.subject.mesh | DNA primers | en_US |
dc.subject.mesh | Enterocolitis, pseudomembranous | en_US |
dc.subject.mesh | Europe | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidence | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Polymerase chain reaction | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.mesh | Young adult | en_US |
dc.title | Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000267464100006 | tr_TR |
dc.identifier.scopus | 2-s2.0-67349184631 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.relation.bap | T-2004-22 | tr_TR |
dc.contributor.orcid | 0000-0002-3894-1231 | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.identifier.startpage | 382 | tr_TR |
dc.identifier.endpage | 387 | tr_TR |
dc.identifier.volume | 39 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Medecine et Maladies Infectieuses | en_US |
dc.contributor.buuauthor | Ergen, E. K. | - |
dc.contributor.buuauthor | Akalın, Halis | - |
dc.contributor.buuauthor | Yılmaz, Emel | - |
dc.contributor.buuauthor | Sınırtaş, Melda | - |
dc.contributor.buuauthor | Alver, Oktay | - |
dc.contributor.buuauthor | Heper, Yasemin | - |
dc.contributor.buuauthor | Özakın, Cüneyt | - |
dc.contributor.buuauthor | Ener, Beyza | - |
dc.contributor.buuauthor | Mstık, Reşit | - |
dc.contributor.buuauthor | Helvacı, Safiye | - |
dc.contributor.researcherid | AAH-6506-2021 | tr_TR |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.contributor.researcherid | AAA-5241-2021 | tr_TR |
dc.contributor.researcherid | AAU-8952-2020 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 19269761 | tr_TR |
dc.subject.wos | Infectious diseases | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 35078341200 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.contributor.scopusid | 22037135100 | tr_TR |
dc.contributor.scopusid | 6505818048 | tr_TR |
dc.contributor.scopusid | 24070021900 | tr_TR |
dc.contributor.scopusid | 56191003300 | tr_TR |
dc.contributor.scopusid | 57200678942 | tr_TR |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.contributor.scopusid | 6602564624 | tr_TR |
dc.contributor.scopusid | 6602103491 | tr_TR |
dc.subject.scopus | Clostridium Infections; Peptoclostridium Difficile; Anti-Bacterial Agents | en_US |
dc.subject.emtree | Ciprofloxacin | en_US |
dc.subject.emtree | Clindamycin | en_US |
dc.subject.emtree | Erythromycin | en_US |
dc.subject.emtree | Metronidazole | en_US |
dc.subject.emtree | Moxifloxacin | en_US |
dc.subject.emtree | Tetracycline | en_US |
dc.subject.emtree | Vancomycin | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Antibiotic sensitivity | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bacterial strain | en_US |
dc.subject.emtree | Bacterium identification | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Clostridium difficile | en_US |
dc.subject.emtree | Clostridium difficile infection | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Disease predisposition | en_US |
dc.subject.emtree | Feces analysis | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Hospital infection | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Incidence | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Polymerase chain reaction | en_US |
dc.subject.emtree | Ribotyping | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | University hospital | en_US |
Appears in Collections: | Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.